GlassScriptPhysician profile
Michelle A Glasgow
NPI 1184882524
$4,502.86
in general payments reported to CMS, 2019-2025
29 companies · $518 in 2025
The $518 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $820 · 2020: $454 · 2021: $241 · 2022: $1,329 · 2023: $539 · 2024: $601 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,658.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $1,230.06 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $615.65 | 2019-2025 | Lynparza |
| Merck Sharp & Dohme LLC | $455.23 | 2019-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Glaxosmithkline, LLC. | $445.23 | 2019-2025 | Jemperli, Zejula |
| Tesaro, INC. | $367.68 | 2019 | |
| Myriad Genetic Laboratories, INC. | $261.82 | 2021-2024 | Myrisk, Mychoice Cdx, Precisetumor |
| Eisai INC. | $170.54 | 2019-2025 | |
| Pfizer INC. | $141.78 | 2019-2025 | |
| Amgen INC. | $118.07 | 2024 | Evenity |
| Caris Mpi, INC. | $104.17 | 2025 | Mi Cancer Seek |
| Seagen INC. | $86.94 | 2023 | Tivdak |
| Clovis Oncology, INC. | $67.69 | 2019-2020 | |
| Coherus Oncology, INC. | $60.29 | 2021-2024 | |
| Astellas Pharma US INC | $53.73 | 2023-2024 | Veozah |
| Ethicon US, LLC | $32.03 | 2021-2023 | Evarrest |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $28.22 | 2025 | Enhertu |
| Kyowa Kirin, INC. | $26.73 | 2019-2020 | |
| Fortovia Therapeutics, INC. | $26.26 | 2019-2020 | |
| Biom'Up France Sas | $25.84 | 2020 | |
| Abbvie INC. | $24.64 | 2025 | |
| Immunogen, INC. | $22.71 | 2023 | Elahere |
| Foundation Medicine, INC. | $21.59 | 2023 | Foundationone Cdx |
| Abbott Laboratories | $21.56 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.60 | 2019 | |
| Solventum Corporation | $16.53 | 2024 | Prevena |
| Davol INC. | $16.46 | 2019 | |
| Prescient Surgical | $15.84 | 2020 | |
| Coopersurgical, INC. | $13.26 | 2019 | |
| Dysis Medical, INC. | $12.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Glasgow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.